vs
Bankwell Financial Group, Inc.（BWFG）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Bankwell Financial Group, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.6倍（$30.3M vs $19.6M），Bankwell Financial Group, Inc.同比增速更快（43.3% vs -11.5%），Bankwell Financial Group, Inc.自由现金流更多（$27.1M vs $-23.1M），过去两年Bankwell Financial Group, Inc.的营收复合增速更高（17.2% vs -12.2%）
Bankwell金融集团是美国的银行控股企业，提供个人及商业银行全品类产品服务，包含存款账户、住房贷款、商业信贷、财富管理解决方案，主要服务康涅狄格州的本地社区、零售客户及中小微企业。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
BWFG vs LAB — 直观对比
营收规模更大
BWFG
是对方的1.6倍
$19.6M
营收增速更快
BWFG
高出54.8%
-11.5%
自由现金流更多
BWFG
多$50.2M
$-23.1M
两年增速更快
BWFG
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.3M | $19.6M |
| 净利润 | — | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 46.9% | -168.5% |
| 净利率 | — | -177.4% |
| 营收同比 | 43.3% | -11.5% |
| 净利润同比 | — | -28.8% |
| 每股收益（稀释后） | $1.16 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BWFGLAB
| Q4 25 | $30.3M | — | ||
| Q3 25 | $28.5M | $19.6M | ||
| Q2 25 | $25.9M | $21.8M | ||
| Q1 25 | $23.6M | $40.8M | ||
| Q4 24 | $21.2M | — | ||
| Q3 24 | $21.9M | $22.1M | ||
| Q2 24 | $21.9M | $22.5M | ||
| Q1 24 | $22.1M | $45.5M |
净利润BWFGLAB
| Q4 25 | — | — | ||
| Q3 25 | $10.1M | $-34.7M | ||
| Q2 25 | $9.1M | $-33.5M | ||
| Q1 25 | $6.9M | $-26.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.9M | $-26.9M | ||
| Q2 24 | $1.1M | $-45.7M | ||
| Q1 24 | $3.8M | $-32.2M |
毛利率BWFGLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率BWFGLAB
| Q4 25 | 46.9% | — | ||
| Q3 25 | 47.3% | -168.5% | ||
| Q2 25 | 45.5% | -118.1% | ||
| Q1 25 | 38.0% | -80.8% | ||
| Q4 24 | 19.2% | — | ||
| Q3 24 | 12.4% | -120.9% | ||
| Q2 24 | 6.7% | -134.5% | ||
| Q1 24 | 23.0% | -132.2% |
净利率BWFGLAB
| Q4 25 | — | — | ||
| Q3 25 | 35.4% | -177.4% | ||
| Q2 25 | 35.0% | -153.7% | ||
| Q1 25 | 29.2% | -63.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.8% | -122.0% | ||
| Q2 24 | 5.1% | -203.3% | ||
| Q1 24 | 17.1% | -70.6% |
每股收益（稀释后）BWFGLAB
| Q4 25 | $1.16 | — | ||
| Q3 25 | $1.27 | $-0.09 | ||
| Q2 25 | $1.15 | $-0.09 | ||
| Q1 25 | $0.87 | $-0.07 | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.24 | $-0.07 | ||
| Q2 24 | $0.14 | $-0.12 | ||
| Q1 24 | $0.48 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $192.1M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $301.5M | $399.7M |
| 总资产 | $3.4B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BWFGLAB
| Q4 25 | $192.1M | — | ||
| Q3 25 | $128.2M | $129.4M | ||
| Q2 25 | $142.6M | $158.6M | ||
| Q1 25 | $136.0M | $150.9M | ||
| Q4 24 | $146.1M | — | ||
| Q3 24 | $145.9M | $210.6M | ||
| Q2 24 | $138.0M | $269.8M | ||
| Q1 24 | $126.2M | $287.1M |
总债务BWFGLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益BWFGLAB
| Q4 25 | $301.5M | — | ||
| Q3 25 | $292.8M | $399.7M | ||
| Q2 25 | $283.3M | $424.5M | ||
| Q1 25 | $275.2M | $454.6M | ||
| Q4 24 | $270.5M | — | ||
| Q3 24 | $267.9M | $489.3M | ||
| Q2 24 | $267.0M | $510.3M | ||
| Q1 24 | $268.0M | $577.3M |
总资产BWFGLAB
| Q4 25 | $3.4B | — | ||
| Q3 25 | $3.2B | $539.6M | ||
| Q2 25 | $3.2B | $557.0M | ||
| Q1 25 | $3.2B | $579.6M | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $3.2B | $681.5M | ||
| Q2 24 | $3.1B | $708.7M | ||
| Q1 24 | $3.2B | $777.7M |
负债/权益比BWFGLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.3M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $27.1M | $-23.1M |
| 自由现金流率自由现金流/营收 | 89.5% | -118.1% |
| 资本支出强度资本支出/营收 | 3.8% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $47.0M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流BWFGLAB
| Q4 25 | $28.3M | — | ||
| Q3 25 | $10.3M | $-22.2M | ||
| Q2 25 | $6.5M | $-20.7M | ||
| Q1 25 | $3.9M | $-30.3M | ||
| Q4 24 | $29.9M | — | ||
| Q3 24 | $-557.0K | $-27.9M | ||
| Q2 24 | $7.1M | $-39.0M | ||
| Q1 24 | $9.0M | $-62.5M |
自由现金流BWFGLAB
| Q4 25 | $27.1M | — | ||
| Q3 25 | $9.9M | $-23.1M | ||
| Q2 25 | $6.1M | $-22.6M | ||
| Q1 25 | $3.8M | $-35.3M | ||
| Q4 24 | $29.3M | — | ||
| Q3 24 | $-672.0K | $-30.1M | ||
| Q2 24 | $6.8M | $-41.0M | ||
| Q1 24 | $8.9M | $-63.3M |
自由现金流率BWFGLAB
| Q4 25 | 89.5% | — | ||
| Q3 25 | 34.9% | -118.1% | ||
| Q2 25 | 23.5% | -103.6% | ||
| Q1 25 | 16.2% | -86.6% | ||
| Q4 24 | 138.6% | — | ||
| Q3 24 | -3.1% | -136.4% | ||
| Q2 24 | 31.0% | -182.2% | ||
| Q1 24 | 40.5% | -138.9% |
资本支出强度BWFGLAB
| Q4 25 | 3.8% | — | ||
| Q3 25 | 1.4% | 4.5% | ||
| Q2 25 | 1.5% | 8.7% | ||
| Q1 25 | 0.4% | 12.4% | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 0.5% | 10.2% | ||
| Q2 24 | 1.7% | 8.6% | ||
| Q1 24 | 0.4% | 1.7% |
现金转化率BWFGLAB
| Q4 25 | — | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.29× | — | ||
| Q2 24 | 6.39× | — | ||
| Q1 24 | 2.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BWFG
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
